NVST
Envista Holdings Corp
NYSE: NVST · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$24.20
+1.01% today
Updated 2026-06-05
Market cap
$4.00B
P/E ratio
60.00
P/S ratio
1.43x
EPS (TTM)
$0.41
Dividend yield
—
52W range
$18 – $30
Volume
3.1M
Envista Holdings Corp (NVST) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$24.20
12-Month target
$13.10
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $2.5B | $2.6B | $2.6B | $2.5B | $2.7B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 2.41%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.